Skip to Content

SunVanish Cream

Generic name: hydroquinone
Dosage form: cream
Drug class: Topical depigmenting agents

Medically reviewed by Drugs.com. Last updated on June 21, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.



Dosage Apply SunVanish in the morning to the affected area or as directed by your physician.



Warnings Contains sodium Metabisulfite, a sulfite that may cause serious allergic type reactions (eg hives, itching, wheezing, anaphylaxis, severe asthma attack) in certain susceptible persons.

For external use only



Distributed by

Genesis Pharmaceuticals Inc

Parsippany, NJ 07054

Made in USA

18004598663

www.glytone.com



Keep out of reach of children



Contains Each gram of SunVanish contains 40 mg of hydroquinone USP, 75 mg of octinoxate and 50 mg of oxybenzone in a cream base of purified water, proplyene glycol, cetostearyl alcohol, glycerin, isopropyl palmitate, sodium metabisulfite, sodium lauryl sulfate, and sorbic acid


Glytone skin bleaching sunvanish with sunscreen

hydroquinone USP, 4%

RX only

Net wt 2 oz (56 g)

SUNVANISH
hydroquinone cream
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:64760-201
Route of Administration TOPICAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYDROQUINONE (HYDROQUINONE) HYDROQUINONE 40 mg in 1 g
Inactive Ingredients
Ingredient Name Strength
WATER
PROPYLENE GLYCOL
CETOSTEARYL ALCOHOL
GLYCERIN
ISOPROPYL PALMITATE
SODIUM METABISULFITE
SODIUM LAURYL SULFATE
SORBIC ACID
Packaging
# Item Code Package Description
1 NDC:64760-201-01 1 TUBE in 1 BOX
1 56 g in 1 TUBE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 10/01/2009 08/20/2014
Labeler - Genesis Pharmaceutical, Inc. (117196928)
Genesis Pharmaceutical, Inc.